These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24418473)

  • 1. Predictors and outcome of low initial forced expiratory volume in 1 second measurement in children with cystic fibrosis.
    Com G; Carroll JL; Castro MM; Tang X; Jambhekar S; Berlinski A
    J Pediatr; 2014 Apr; 164(4):832-8. PubMed ID: 24418473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
    Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
    Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucus removal is impaired in children with cystic fibrosis who have been infected by Pseudomonas aeruginosa.
    Laube BL; Sharpless G; Benson J; Carson KA; Mogayzel PJ
    J Pediatr; 2014 Apr; 164(4):839-45. PubMed ID: 24373575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of nutritional status, plasma, albumin levels and pulmonary function in cystic fibrosis.
    Souza dos Santos Simon MI; Drehmer M; de Abreu E Silva FA; Hoffmann A; Druck Ricachinewsky C; de Fonseca Andrade Procianoy E; Scattolin I; Saldanha Menna Barreto S
    Nutr Hosp; 2011; 26(6):1322-7. PubMed ID: 22411378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
    Cogen J; Emerson J; Sanders DB; Ren C; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Pediatr Pulmonol; 2015 Aug; 50(8):763-70. PubMed ID: 26061914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.
    Lechtzin N; John M; Irizarry R; Merlo C; Diette GB; Boyle MP
    Respiration; 2006; 73(1):27-33. PubMed ID: 16113513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use.
    McPhail GL; Acton JD; Fenchel MC; Amin RS; Seid M
    J Pediatr; 2008 Dec; 153(6):752-7. PubMed ID: 18760423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
    Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K
    J Pediatr; 2001 May; 138(5):699-704. PubMed ID: 11343046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in lung function is associated with worse clinical outcomes in cystic fibrosis.
    Heinzmann-Filho JP; Pinto LA; Marostica PJ; Donadio MV
    J Bras Pneumol; 2015; 41(6):509-15. PubMed ID: 26785959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.
    Morgan WJ; Wagener JS; Yegin A; Pasta DJ; Millar SJ; Konstan MW; ;
    J Pediatr; 2013 Oct; 163(4):1152-7.e2. PubMed ID: 23810128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative outcomes and quality of life in patients with cystic fibrosis undergoing laparoscopic cholecystectomy: a retrospective study.
    Cogliandolo A; Patania M; Currò G; Chillè G; Magazzù G; Navarra G
    Surg Laparosc Endosc Percutan Tech; 2011 Jun; 21(3):179-83. PubMed ID: 21654302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.
    Sanders DB; Fink A; Mayer-Hamblett N; Schechter MS; Sawicki GS; Rosenfeld M; Flume PA; Morgan WJ
    J Pediatr; 2015 Nov; 167(5):1081-8.e1. PubMed ID: 26340874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Johnson CA; Butler SM; Konstan MW; Breen TJ; Morgan WJ
    J Pediatr; 1999 Jun; 134(6):734-9. PubMed ID: 10356143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
    Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
    Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between FEV1 and peak oxygen uptake in children with cystic fibrosis.
    Pianosi P; LeBlanc J; Almudevar A
    Pediatr Pulmonol; 2005 Oct; 40(4):324-9. PubMed ID: 16082708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.